Keywords: تنفوفیر آلفانامید; 3TC; lamivudine; ABC; abacavir; ACN; acetonitrile; aCSF; artificial cerebrospinal fluid; CNS; central nervous system; CSF; cerebrospinal fluid; ER; extraction recovery; ESI; electrospray ionization; FA; formic acid; FTC; emtricitabine; FWHM; full width at
مقالات ISI تنفوفیر آلفانامید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تنفوفیر آلفانامید; ARV; antiretroviral; CHO; Chinese Hamster Ovary; CID; collision-induced dissociation; DMEM/F12; Dulbecco's Modified Eagle's Medium: Ham's F12 Medium; DMF; dimethylformamide; DMSO; dimethylsulfoxide; GGT; γ-glutamyltransferase; HIV; human immunodefi
Keywords: تنفوفیر آلفانامید; Inflammation; Immune activation; Biomarkers; Tenofovir alafenamide;
Keywords: تنفوفیر آلفانامید; Tenofovir alafenamide; Tenofovir diphosphate; Resistance; Tenofovir disoproxil fumarate; HIV-1;
Rare emergence of drug resistance in HIV-1 treatment-naïve patients receiving elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide for 144 weeks
Keywords: تنفوفیر آلفانامید; HIV-1; Tenofovir; Tenofovir alafenamide; Tenofovir disoproxil fumarate; M184V; Integrase strand transfer inhibitor resistance (INSTI-R);
Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid
Keywords: تنفوفیر آلفانامید; Tenofovir; Tenofovir alafenamide; Plasma; Cerebrospinal fluid; Mass spectrometry;
GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus
Keywords: تنفوفیر آلفانامید; ABC; abacavir; ABVD; adriamycin, bleomycin, vinblastine and dacarbazine; Ara-C; cytosine arabinoside; AZT; zidovudine; BCNU; carmustine; BEACOPP; bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone; CDC; Centers fo
Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model study
Keywords: تنفوفیر آلفانامید; Combination antiretroviral drugs; Nanoparticles; HIV-1 treatment; Humanized mice model; Tenofovir alafenamide; Elvitegravir; Emtricitabine;
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements
Keywords: تنفوفیر آلفانامید; AASLD; American Association for the Study of Liver Diseases; ADV; adefovir dipivoxil; ALT; alanine aminotransferase; Anti-HBe; antibodies to hepatitis B envelope antigen; anti-HBs; antibody to hepatitis B surface antigen; APASL; Asian Pacific Association
Tenofovir alafenamide (TAF) does not deplete mitochondrial DNA in human T-cell lines at intracellular concentrations exceeding clinically relevant drug exposures
Keywords: تنفوفیر آلفانامید; Mitochondrial toxicity; mtDNA synthesis; T-cells; NRTI; TAF; Tenofovir alafenamide; d4T; stavudine; ddC; dideoxycytidine; ddI; dideoxyinosine; NRTI; nucleoside reverse transcriptase inhibitor; PBMC; peripheral blood mononuclear cell; TAF; tenofovir alafen
Simultaneous determination of tenofovir alafenamide and its active metabolites tenofovir and tenofovir diphosphate in HBV-infected hepatocyte with a sensitive LC-MS/MS method
Keywords: تنفوفیر آلفانامید; Tenofovir alafenamide; Tenofovir diphosphate; Tenofovir; LC-MS/MS; Intracellular pharmacokenetics;
Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance
Keywords: تنفوفیر آلفانامید; ART; antiretroviral therapy; TasP; Treatment-as-Prevention; NRTI; nucleoside reverse transcriptase (RT) inhibitor; NNRTI; non-nucleoside RT inhibitor; PI; protease inhibitor; INSTI; integrase strand transfer inhibitor; RAL; raltegravir; EVG; elvitegravir;
Prodrugs - Recent approvals and a glimpse of the pipeline
Keywords: تنفوفیر آلفانامید; Prodrug; Aripiprazole lauroxil; Isavuconazonium; Ixazomib; Sacubitril; Selexipag; Tenofovir alafenamide; Uridine triacetate; Telotristat etiprate;
Research ArticleTwenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection
Keywords: تنفوفیر آلفانامید; CHB; chronic hepatitis B; HBsAg; hepatitis B surface antigen; TDF; tenofovir disoproxil fumarate; TFV; tenofovir; TAF; tenofovir alafenamide; TFV-DP; tenofovir diphosphate; PBMC; peripheral blood mononuclear cells; eGFR; estimated glomerular filtration ra